Journal article
Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA). Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCIC CTG and the EORTC GCG
Authors
Pfisterer J; Plante M; Vergote I; Du Bois A; Wagner U; Hirte H; Lacave AJ; Stähle A; Kimmig R; Eisenhauer E
Journal
Journal of Clinical Oncology, Vol. 22, No. 14_suppl, pp. 5005–5005
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
July 15, 2004
DOI
10.1200/jco.2004.22.14_suppl.5005
ISSN
0732-183X